Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of Verekitug in participants with Chronic Obstructive Pulmonary Disease and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verekitug (UPB-101)

Snippet

Sponsor: Upstream Bio Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: RECRUITING